Obesity is associated with an increased risk of total cardiovascular disease mortality (Kuriyama 2006; Funada et al. 2008) . In Japan, the prevalence of overweight individuals has increased among men and elderly women in the last 20 years (Yoshiike et al. 2002) . The impact of obesity upon medical costs is as large as in Western countries, despite the much lower mean body mass index (BMI) in Japanese (Kuriyama et al. 2002) . The development of an effective approach to the control of obesity and prevention of obesity-associated diseases is of great importance.
Obesity is a multi-factorial disease, determined largely by lifestyle factors, such as food intake and physical activity, but also by genetic factors (Lee 2009) . Leptin is an adipocyte-derived blood-borne satiety factor that acts on its cognate leptin receptor in the hypothalamus, thereby regulating food intake and energy expenditure (Matsuoka et al. 1997) . The taste organ was found to be one of the peripheral targets of leptin. The hormone specifically inhibited sweet taste responses in lean mice but not in db/db mice (Kawai et al. 2000) .
A common polymorphism of the leptin receptor (LEPR) gene, replacing lysine with arginine at codon 109 (AAG to AGG) in exon 4 (Lys109Arg), was associated with insulin and glucose metabolism in women with impaired glucose homeostasis (Lakka et al. 2004) . Wauters et al. (2002) reported that leptin levels were higher in Lys109Arg heterozygotes among postmenopausal women. Rosmond et al. (2000) reported that when BMI and leptin were elevated, increased blood pressure was found with the most prevalent LEPR genotype at codon 109, whereas the variant genotype seemed to protect against hypertension. This polymorphism was also found to be associated with obesity along with sweet preference (Mizuta et al. 2008) . On the other hand, Mars et al. (2004) reported no effect of polymorphisms in the LEPR gene on the acute decline in leptin after energy restriction.
Previous studies have suggested a relationship between weight loss and changes in sweet taste. Scruggs et al. (1994) , for instance, reported that weight loss following gastric bypass surgery was associated with up-regulated sweet taste acuity in the morbidly obese patients. Burge et al. (1995) also observed that patients' mean recognition thresholds for sucrose fell significantly 12 weeks after having undergone Roux-en-Y gastric bypass for clinically severe obesity. Bolze et al. (1982) reported that alterations in taste acuity, but not plasma zinc levels, were associated with weight loss during radiotherapy.
However, the subjects of previous studies reporting a relationship between weight loss and sweet taste were diseased patients undergoing particular therapies. Additionally, these studies did not evaluate the influence of serum leptin and LEPR polymorphisms on sweet taste. It is therefore important to investigate preclinical and obese subjects for the prevention of common lifestyle-related diseases. In the present study, we investigated changes in serum leptin levels and the sweet taste threshold during a weight-loss program and simultaneously examined whether LEPR polymorphisms affected this taste change in obese females.
Subjects and Methods
A total of 20 otherwise healthy and free-living Japanese females, with a mean age of 55 ± 7 years, mean weight of 61.7 ± 4.6 kg and mean BMI of 26.1 ± 1.7 kg/m² (range 24.1-30.9), participated in this study. The study was approved by the ethics committee of Kyoto Medical Center, and all the subjects gave informed consent. Participants were recruited as part of a 12-week weight-loss program held by a public health center in Kyoto City, Japan.
Their general condition and blood measures were examined before and after the program. Blood pressure was measured using an automatic digital monitor (A&D, Tokyo, Japan). Body weight and height were measured using a load cell scale (Kansai-Seiki, Kyoto, Japan). Body fat was measured with a body fat analyzer (Omron, Kyoto, Japan). Venous blood samples were then taken. Blood hemoglobin A 1C (HbA 1C ) was measured by high performance liquid chromatography (HPLC) (ADAMS TM A 1C ; HA-8160, ARKRAY, Kyoto, Japan). Leptin was measured by a radioimmuno-assay (SRL, Tokyo, Japan). Zinc was measured with an atomic absorption spectrophotometer (flame type). Iron was measured by the bathophenanthroline method. Copper was measured by a colorimetric method. Nutritional intake was assessed with a semi-quantitative food frequency questionnaire (Sasaki et al. 1998 ).
Weight-loss program
During a 12-week intervention, subjects attended five lectures about diet in a small group setting. They were provided with educational modalities such as pedometers, weight diaries, maps to record steps per day and action plan sheets. At the group session, doctors, public health nurses, registered dieticians and exercise trainers, named 'lifestyle coaches', were involved as facilitators. The topics of the sessions included weight control, healthy eating and physical activities. The facilitators tried to make a session as interactive as possible using food models and/or body fat models.
Sweet taste tests
The sweet taste threshold was determined according to the whole-mouth gustatory method (Yamauchi et al. 2002) . Briefly, the subjects were tested at least 10 hours after their last meal. The compound used was a solution of sucrose dissolved in sterile water. Ten concentrations (0.0098, 0.0195, 0.0391, 0.0781, 0.1560, 0.3130, 0.6250, 1.2500, 2.5000 and 5.0000%) were prepared through serial dilution. We used a forced-choice, staircase procedure to measure detection thresholds for the sweet taste stimulus. A two-down, one-up rule was employed (i.e. the stimulus concentration was lowered after two successive correct trials, and raised after a single incorrect trial). Two cups of solution and sterile water were presented in order of ascending concentrations, sipped from the cups, and tasted in the whole mouth. They were not swallowed, and the mouth was rinsed between each session. Then, the subject had to choose the solution correctly. Trials continued until three reversals occurred (a reversal in our staircase method is defined as a change in the direction of stimulus intensity adjustment; a decrease in stimulus level immediately following an increase). The geometric mean of the concentrations at which three reversals occurred was regarded as the detection threshold of sweet taste.
Genetic analysis
A noninvasive sampling method was implemented for collecting buccal mucosa cells using cytobrushes. After the phenol-extraction procedure, 0.2 to 2 µ g of DNA per subject was obtained. Genotypes were determined with an intercalater-mediated fluorescent allele-specific DNA assay (Toyobo Gene Analysis, Tsuruga, Japan). The Lys109Arg LEPR polymorphic region (rs1137100) was amplified using the polymerase chain reaction (PCR) with sense primers (5´-AG TGAGCAAGATAGAAACTGCTCCTTATGTG-3´), and anti-sense primers (5´-TGCTTACCTATTTGTTGAAAAACTAAAGAATTTAC TGG-3´), labeled at the 5´ end with Texas red (5´-CATTGAAGGAA GGACATTTGTTT-3´). PCR was performed under the conditions recommended by the enzyme's manufacturer. In brief, a 25 µ l aliquot contained 20 ng of genomic DNA, the reaction buffer supplied, 3.0 mM MgCl2, 0.2 mM dNTP, and 1.25 U of rTaq containing anti-Taq high (TOYOBO, Tsuruga, Japan). Cycling parameters were as follows: after denaturation at 95ºC for 5 min, denaturation at 95ºC for 30 sec, annealing at 65ºC for 30 sec, and primer extension at 72ºC for 30 sec for 40 cycles and post-extension at 72ºC for 2 min in a thermal cycler (ABI9700). A 2 µ l reaction mixture containing 10 pmol of probe and SYBR Green I (final concentration, × 10000) was added to the PCR products. The mixture was put into the ABI PRIZM 7700 and the melting temperature was measured. The program for analytical melting was 95ºC for 30 sec, and 40ºC for 1 min, increasing to 80ºC in 10 min. The fluorescence signals were detected at excitation and emission wavelengths of 485 nm and 612 nm, respectively.
Statistical analysis
Data are expressed as the mean ± S.D. The t test was used to Table 1 . Anthropometrical and biochemical parameters and nutritional intake before and after the progrum. compare the difference in continuous variables between the subjects without the Lys109 allele (Arg109/Arg109) and those with the Lys109 allele (Lys109/Arg109 or Lys109/Lys109). The paired t test was used to examine the change in levels before and after the study. HardyWeinberg equilibrium was analyzed with Fisher's exact test. The correlations between the changes in serum leptin levels and adjusted variables (model 1: initial sweet taste and weight loss; model 2: initial sweet taste and change in serum leptin; model 3: Initial sweet taste, change in serum leptin, Lys 109 allele) were examined in a multiple regression model. All statistical analyses were performed with the Statistical Package of Social Science (SPSS for Windows, Chicago, USA).
Results
The distribution of the Arg109/Arg109, Lys109/Arg109 and Lys109/Lys109 genotypes was 14, 5 and 1, respectively. The frequency of the Lys allele was 0.18. All genotypes were in Hardy-Weinberg equilibrium.
The physical and biochemical characteristics of all the subjects are listed in Table 1 . At baseline, there was no difference in mean age, BMI, fasting plasma glucose levels, systolic blood pressure, diastolic blood pressure and hemoglobin A 1C between subjects with the non-Lys109 allele (Arg109/Arg109) and those with the Lys109 allele (Lys109/ Lys109 and Lys109/Arg109).
During the program, average energy intake (from 2027 ± 578 kcal/day to 1717 ± 472 kcal/day, p < 0.001) and body weight (from 61.7 ± 4.6 kg to 58.1 ± 5.2 kg, p < 0.001) decreased significantly, in a manner similar to BMI, waist circumference and body fat percentage ( p < 0.001, respectively). Serum leptin levels were also decreased significantly from 9.2 ± 4.5 to 7.9 ± 4.9 ng/ml ( p = 0.014). The sweet taste threshold decreased significantly from 0.59 ± 0.42% to 0.22 ± 0.20% ( p = 0.004). There was no difference in the change to the sweet taste threshold between the groups with versus without the Lys109 allele. There was a significant difference in the change in serum leptin levels between the groups ( p < 0.028).
In adjusted correlation analyses (Table 2) , the change in serum leptin levels was significantly correlated with that in the sweet taste threshold, independent of the threshold before the program and the other adjusted variables (in models 1-3).
Discussion
This study showed that the decrease in serum leptin levels was significantly associated with the decrease in sweet taste threshold during weight loss in otherwise healthy and obese females. The present findings are valuable in showing the significant correlation between the change in the sweet taste threshold and serum leptin levels before and after weight loss in an otherwise healthy obese population, which is just a target of the control of an increase in lifestyle-related disease.
Leptin is an adipocyte-secreted hormone that regulates food intake, energy expenditure and body weight. The peripheral taste organ is one of the targets of leptin. In lean mice, leptin selectively suppresses gustatory neural and behavioral responses to sweet compounds without affecting responses to other taste stimuli, whereas in obese diabetic db/db mice with defects in the leptin receptor, this suppression is lacking (Kawai et al. 2000) . In human experiments, the recognition thresholds for sweet compounds exhibited a diurnal variation from 0800 to 2000 h that paralleled the variation in leptin levels, with the lowest thresholds in the morning and the highest at night (Nakamura et al. 2008) . We speculated that the changes in leptin could induce the improvement of sweet taste during weight-loss. Further examination is needed to clarify these points.
Serum leptin levels in Lys109 carriers significantly decreased with weight loss, although those in non-carriers did not change after weight loss. The reason for the discrepancy in responsiveness to weight loss between those with and those without the Lys109 allele is unclear. It was reported that weight gainers with Arg109 had higher leptin levels than non-carriers of this allele based on two large prospective cohorts in the Netherlands (van Rossum et al. 2003) . They suggested the impaired signaling of leptin in the Arg109 variants. These findings might explain why serum leptin levels in Lys109 carriers did not change after CI, confidence interval. Model 1 is adjusted for initial sweet taste and weight loss. Model 2 is adjusted for initial sweet taste and change in serum leptin. Model 3 is adjusted for initial sweet taste, change in serum leptin and Lys 109 allele in the leptin receptor. weight loss.
There are several limitations to consider. The sample size of this study was small. Further examinations using more samples are needed. Additionally, males as well as different ethnic groups should be examined to generalize the present findings. Moreover, menopausal state reportedly affects leptin metabolism, thought conflicting findings exist (Di Carlo et al. 2002) . This study did not include data on menopausal state. Finally, Koh et al. (2002) indicated the Gly223Arg polymorphism of the LEPR gene to be important for the determination of peak bone mass in males. Wauters et al. (2002) reported that the Lys656Asn polymorphism of the LEPR gene affected substrate oxidation. We also need to assess the association with sweet taste thresholds of other leptin receptor polymorphisms such as Gln223Arg as well as serum leptin levels.
In summary, these findings suggest that weight loss can lead to an improvement in sweet taste, which may be in part accounted for by the decrease in leptin in obese females. The change in sweet taste was unlikely related to the initial taste threshold and the LEPR polymorphisms. These findings may guide the control of obesity and diet treatment in the preventative stage.
